2D-XRCC3 (Thr241Met) Genotypes

Allele Frequency (%)

Thr/Thr

Thr/Met

Met/Met

Thr

Met

Control Group (n = 100)

37 (37.0)

52 (52.0)

11 (11.0)

63.0

37.0

Patient Group (n = 90)

36 (40.0)

40 (44.4)

14 (15.6)

62.2

37.8

χ2 = 1.41, p = 0.49

χ2 = 0.02, p = 0.88

Merged Genotypes

Thr/Thr

Thr/Met + Met/Met

Control Group (n = 100)

37 (37.0)

63 (63.0)

Patient Group (n = 90)

36 (40.0)

54 (60.0)

χ2 = 0.18, p = 0.67

OR (95% CI) = 0.8 (0.3 - 2.5)